Positive News SentimentPositive NewsNASDAQ:OMIC Singular Genomics Systems (OMIC) Stock Price, News & Analysis $13.32 +0.32 (+2.46%) (As of 10/31/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends About Singular Genomics Systems Stock (NASDAQ:OMIC) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get OMIC alerts:Sign Up Key Stats Today's Range$12.55▼$14.1150-Day Range$5.50▼$16.7952-Week Range$5.34▼$19.80Volume57,472 shsAverage Volume34,027 shsMarket Capitalization$33.25 millionP/E RatioN/ADividend YieldN/APrice Target$10.75Consensus RatingHold Company OverviewSingular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology for researchers and clinicians to advance science and medicine. The company is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as max read kits for single cell sequencing, rare variant detection with high-definition sequencing, gene fusion detection with ring-seq, and extended range sequencing; and PX instrument and associated consumables for applications comprising single cell gene expression and proteomics, in situ RNA sequencing, and spatial RNA and proteomics applications for tissue. Singular Genomics Systems, Inc. was incorporated in 2016 and is based in San Diego, California.Read More… Protect Your Bank Account with THESE 4 Simple Steps (Ad)Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.Learn these 4 simple steps and protect your savings before it’s too late. Singular Genomics Systems Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks33rd Percentile Overall ScoreOMIC MarketRank™: Singular Genomics Systems scored higher than 33% of companies evaluated by MarketBeat, and ranked 846th out of 997 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.0 / 5Analyst RatingHold Consensus RatingSingular Genomics Systems has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageSingular Genomics Systems has received no research coverage in the past 90 days.Read more about Singular Genomics Systems' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Singular Genomics Systems is -0.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Singular Genomics Systems is -0.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSingular Genomics Systems has a P/B Ratio of 0.18. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Singular Genomics Systems' valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted5.93% of the float of Singular Genomics Systems has been sold short.Short Interest Ratio / Days to CoverSingular Genomics Systems has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Singular Genomics Systems has recently decreased by 14.42%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldSingular Genomics Systems does not currently pay a dividend.Dividend GrowthSingular Genomics Systems does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted5.93% of the float of Singular Genomics Systems has been sold short.Short Interest Ratio / Days to CoverSingular Genomics Systems has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Singular Genomics Systems has recently decreased by 14.42%, indicating that investor sentiment is improving significantly. News and Social Media2.7 / 5News SentimentN/A News SentimentSingular Genomics Systems has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.68 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Singular Genomics Systems this week, compared to 1 article on an average week. Company Ownership4.2 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Singular Genomics Systems insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,166.00 in company stock.Percentage Held by Insiders22.20% of the stock of Singular Genomics Systems is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions65.80% of the stock of Singular Genomics Systems is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Singular Genomics Systems' insider trading history. Receive OMIC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Singular Genomics Systems and its competitors with MarketBeat's FREE daily newsletter. Email Address OMIC Stock News HeadlinesSingular Genomics Systems (NASDAQ:OMIC) Shares Down 0.7% - What's Next?October 22, 2024 | americanbankingnews.comSingular Genomics falls as Tang's Concentra offers $12 a shareSeptember 20, 2024 | msn.comUrgent: This election is riggedIf you missed it, my emergency election broadcast is now available - but will be removed soonOctober 31, 2024 | Porter & Company (Ad)Singular Genomics Systems, Inc.: Singular Genomics Receives Non-Binding Acquisition Proposal from Concentra Biosciences and Tang CapitalSeptember 20, 2024 | finanznachrichten.deSingular Genomics Gets Acquisition Proposal from Concentra BiosciencesSeptember 19, 2024 | marketwatch.comSingular Genomics Receives Non-Binding Acquisition Proposal from Concentra Biosciences and Tang CapitalSeptember 19, 2024 | globenewswire.com$1.8M Bet On Singular Genomics? Check Out These 3 Stocks Executives Are BuyingSeptember 19, 2024 | benzinga.comTANG CAPITAL MANAGEMENT LLC Acquires New Stake in Singular Genomics Systems IncSeptember 19, 2024 | finance.yahoo.comSee More Headlines OMIC Stock Analysis - Frequently Asked Questions How have OMIC shares performed this year? Singular Genomics Systems' stock was trading at $13.8030 at the start of the year. Since then, OMIC shares have decreased by 2.3% and is now trading at $13.49. View the best growth stocks for 2024 here. How were Singular Genomics Systems' earnings last quarter? Singular Genomics Systems, Inc. (NASDAQ:OMIC) posted its earnings results on Tuesday, August, 13th. The company reported ($8.57) EPS for the quarter, topping the consensus estimate of ($8.86) by $0.29. The company had revenue of $0.74 million for the quarter, compared to analysts' expectations of $0.40 million. Singular Genomics Systems had a negative net margin of 3,375.72% and a negative trailing twelve-month return on equity of 54.66%. When did Singular Genomics Systems' stock split? Singular Genomics Systems shares reverse split on Wednesday, June 26th 2024. The 1-30 reverse split was announced on Wednesday, June 26th 2024. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, June 26th 2024. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split. When did Singular Genomics Systems IPO? Singular Genomics Systems (OMIC) raised $178 million in an initial public offering on Thursday, May 27th 2021. The company issued 8,500,000 shares at $20.00-$22.00 per share. J.P. Morgan, Goldman Sachs, BofA Securities, Cowen and UBS Investment Bank acted as the underwriters for the IPO. How do I buy shares of Singular Genomics Systems? Shares of OMIC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Singular Genomics Systems own? Based on aggregate information from My MarketBeat watchlists, some other companies that Singular Genomics Systems investors own include NVIDIA (NVDA), Tesla (TSLA), Albemarle (ALB), CrowdStrike (CRWD), Etsy (ETSY), Ford Motor (F) and Fluence Energy (FLNC). Company Calendar Last Earnings8/13/2024Today10/31/2024Next Earnings (Estimated)11/12/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Analytical instruments Sub-IndustryMeasuring And Control Equipment Current SymbolNASDAQ:OMIC CUSIPN/A CIK1850906 Websingulargenomics.com Phone858-333-7830FaxN/AEmployees220Year FoundedN/APrice Target and Rating Average Stock Price Target$10.75 High Stock Price Target$15.00 Low Stock Price Target$6.50 Potential Upside/Downside-21.1%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($37.70) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-94,820,000.00 Net Margins-3,375.72% Pretax Margin-3,375.72% Return on Equity-54.66% Return on Assets-36.42% Debt Debt-to-Equity Ratio0.05 Current Ratio8.77 Quick Ratio8.04 Sales & Book Value Annual Sales$2.72 million Price / Sales12.49 Cash FlowN/A Price / Cash FlowN/A Book Value$73.25 per share Price / Book0.19Miscellaneous Outstanding Shares2,496,000Free Float1,942,000Market Cap$34.02 million OptionableOptionable Beta1.49 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report This page (NASDAQ:OMIC) was last updated on 10/31/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored“Buffett Indicator” Predicts 62% Stock Market CrashThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredTrump or Kamala? It may come down to this strange twist…Could this be the key to America's second coming? A strange resurrection born in the hollers of Appalachia? ...Porter & Company | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | SponsoredGold at $2,600... But This Stock Gives You More for Under $20Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an...Monument Traders Alliance | SponsoredCNBC’s ‘Prophet’ issues urgent Fed warning"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Singular Genomics Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Singular Genomics Systems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.